Mounjaro Shortage 2025

Mounjaro Shortage 2025. Some patients fear tirzepatide, sold by eli lilly under the brand names zepbound and mounjaro, will be hard to get and prohibitively expensive once compounding pharmacies. In the most recent quarter, mounjaro generated $3.1 billion in sales, while zepbound brought in $1.2 billion.

Demand for the company’s weight loss and diabetes drugs has outpaced its supply. Manufacturer moves to correct inaccurate reporting on the availability of mounjaro mandatory.